Placebo Controlled Trial of Bosentan in Scleroderma Patients

NCT00377455 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Study was terminated due to inadequate enrolment

Conditions

Systemic Scleroderma
Pulmonary Hypertension

Interventions

DRUG: Bosentan
DRUG: Placebo

Sponsor

Georgetown University

Collaborators

[object Object]